Literature DB >> 177712

Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.

L H Perrin, B S Joseph, N R Cooper, M B Oldstone.   

Abstract

Antibody-mediated C-dependent lysis of cell lines infected with herpes simplex type 1 virus, influenza A degrees virus, measles virus, and mumps virus occurred by the alternative C pathway with the participation of IgG antibodies. Lysis occurred only with immune human sera, Mg++ EGTA immune sera, and immune sera depleted of C4 or treated with Fab anti-C4. Lysis did not occur with nonimmune sera, Mg++ EDTA immune sera, and immune sera heated 50 degrees C for 25 min, depleted of factor B or treated with Fab antifactor B. Lysis was restored to heated and factor B immunodepleted immune sera by addition of factor B, but not by addition of an excess of C2. Further studies showed that lysis of HeLa cells infected with measles virus was induced by both immune IgG and F(ab')2 but not Fab' in the presence of a nonantibody-containing human C source. Lysis of measles virus-infected cells was also indpendent of movement of viral antigens on the surface of the infected cells, as inhibition of viral antigen capping by cytochalasin B or sodium azide was not associated with abrogation of immune lysis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177712      PMCID: PMC2190191          DOI: 10.1084/jem.143.5.1027

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Human lymphocyte cytotoxicity against mumps virus-infected target cells. Requirement for non-T cells.

Authors:  B Härfast; T Andersson; P Perlmann
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

2.  A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus.

Authors:  R DULBECCO; M VOGT; A G STRICKLAND
Journal:  Virology       Date:  1956-04       Impact factor: 3.616

3.  Lysis of tumor cells by antibody and complement. II. Lack of correlation between amount of C4 and C3 fixed and cell lysis.

Authors:  S H Ohanian; T Borsos
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

4.  Biologically active water-insoluble protein polymers. I. Their use for isolation of antigens and antibodies.

Authors:  S Avrameas; T Ternynck
Journal:  J Biol Chem       Date:  1967-04-10       Impact factor: 5.157

5.  Activation of human complement by human lymphoid cells sensitized with histocompatibility alloantisera.

Authors:  S Ferrone; N R Cooper; M A Pellegrino; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

6.  The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.

Authors:  P J Lachmann
Journal:  Immunochemistry       Date:  1971-01

7.  Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line.

Authors:  A C Ehrnst
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

8.  Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway.

Authors:  B S Joseph; N R Cooper; M B Oldstone
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

9.  Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor.

Authors:  R D Schreiber; R G Medicus; O Gïtze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

10.  THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS.

Authors:  H L SPIEGELBERG; W O WEIGLE
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

View more
  35 in total

1.  Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection.

Authors:  K E Wright; M J Buchmeier
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes.

Authors:  L H Perrin; R M Zinkernagel; M B Oldstone
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

3.  Generation of virus-specific cytolytic activity in human peripheral lymphocytes after vaccination with vaccinia virus and measles virus.

Authors:  L H Perrin; D Reynolds; R Zinkernagel; M B Oldstone
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

4.  Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus?

Authors:  M B Oldstone; A Tishon; F J Dutko; S I Kennedy; J J Holland; P W Lampert
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

5.  Cellular immunity to possible synovial antigens in rheumatoid arthritis.

Authors:  A D Robinson; K D Muirden
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

6.  Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.

Authors:  C R Lambre; M Thibon; S Le Maho; G Di Bella
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

7.  [Problems of intravenous gammaglobulin therapy (author's transl)].

Authors:  J Ring; K H Duswald
Journal:  Klin Wochenschr       Date:  1980-08-15

8.  Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.

Authors:  M T Aguado; L H Perrin; R Ramirez; P A Miescher; P H Lambert
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

9.  Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies.

Authors:  J H Mathews; J T Roehrig; D W Trent
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Antibody-dependent cytotoxicity against Trypanosoma rhodesiense mediated through an alternative complement pathway.

Authors:  B Flemmings; C Diggs
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.